Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2025 Earnings Call Transcript November 6, 2025
Amylyx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.37, expectations were $-0.43.
Operator: Good morning. My name is Carly, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals third quarter earnings conference call. [Operator Instructions] Please be advised that this call is being recorded at the...
